Business Context and Reporting Period
Lectec Corporation (noting the input metadata reference to Axogen, Inc. which appears to be an error as the filing is for Lectec) filed a Form 10-Q for the quarterly period ended September 30, 2001. The Company manufactures and sells products based on advanced skin interface technologies. Notably, the Board of Directors approved a change in the fiscal year-end from June 30 to December 31, effective immediately, requiring a transition report for the six months ended December 31, 2001.
Key Financial Metrics
- Net Sales: $2,725,261 for the three months ended September 30, 2001.
- Gross Profit: $940,681 (34.5% margin).
- Net Loss: $(1,190,124), or $(0.30) per share.
- Operating Cash Flow: Net cash used in operating activities was $(1,333,745).
- Liquidity: Cash and cash equivalents totaled $1,943,465 at period end. Working capital was $3,142,106 with a current ratio of 2.3.
- Debt: No borrowings were outstanding on the $2.8 million line of credit. Long-term obligations (mortgage) totaled $851,667 excluding current maturities.
Material Changes Versus Prior Period
Compared to the three months ended September 30, 2000, the Company experienced significant declines in revenue and profitability:
- Revenue Decline: Net sales decreased 34.9% to $2.73 million from $4.19 million. This was driven by a 57.0% drop in conductive product sales following the sale of those assets in April 2001, a 100% drop in medical tape sales due to business exit, and a 17.1% decline in therapeutic consumer products due to reduced customer demand and economic softening.
- Profitability Deterioration: Gross profit fell 42.4% to $940,681. The gross margin percentage decreased from 39.0% to 34.5%, attributed to a manufacturing and supply agreement requiring the Company to supply products to the buyer of the conductive assets at cost (plus 10% after October 2001).
- Loss Expansion: The net loss more than doubled from $(597,901) in the prior year period to $(1,190,124).
- Cash Position: Cash and cash equivalents decreased by $1.43 million, primarily due to the net loss and a reduction in accounts payable days.
Outlook, Risks, and Management Commentary
Management expects decreased conductive product sales to continue as the Company fulfills a supply agreement through January 31, 2002. The Company is in the process of extending its secured line of credit for an additional two years with a maximum borrowing of $2.0 million. Management believes existing cash, internally generated cash flow, and the credit line will support operations through September 30, 2002, though future capital infusions may be required for long-term growth.
Risks and Contingencies:
- Restructuring: A restructuring accrual of $216,075 remains for the wind-down of the conductive business, expected to be completed by June 30, 2002.
- Market Conditions: Sales are impacted by retailer reluctance to build inventory due to economic softening and uncertainties following the September 11, 2001 events.
- Capital Needs: There is no assurance that future capital infusions will be available if desired sales or profitability levels are not achieved.
Investor Verification Checklist
- Verify the status and terms of the extension for the $2.0 million secured line of credit.
- Monitor the execution of the Manufacturing and Supply Agreement for conductive products and its impact on margins through January 2002.
- Assess the progress of the restructuring plan and the utilization of the $216,075 accrual.
- Review the impact of the fiscal year-end change on future reporting comparability.
- Confirm the Company's ability to meet the $154,482 purchase commitment for production machinery due in the quarter ended December 31, 2001.